This article has Open Peer Review reports available.
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
© Kontovinis et al; licensee BioMed Central Ltd. 2009
Received: 08 October 2008
Accepted: 12 March 2009
Published: 12 March 2009
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|8 Oct 2008||Submitted||Original manuscript|
|10 Nov 2008||Reviewed||Reviewer Report - Torgny Rasmuson|
|8 Dec 2008||Reviewed||Reviewer Report - Grant McArthur|
|7 Jan 2009||Author responded||Author comments - Konstantinos Papazisis|
|Resubmission - Version 2|
|7 Jan 2009||Submitted||Manuscript version 2|
|5 Feb 2009||Reviewed||Reviewer Report - Torgny Rasmuson|
|10 Feb 2009||Reviewed||Reviewer Report - Grant McArthur|
|5 Mar 2009||Author responded||Author comments - Konstantinos Papazisis|
|Resubmission - Version 3|
|5 Mar 2009||Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|7 Mar 2009||Author responded||Author comments - Konstantinos Papazisis|
|Resubmission - Version 5|
|7 Mar 2009||Submitted||Manuscript version 5|
|12 Mar 2009||Editorially accepted|
|12 Mar 2009||Article published||10.1186/1471-2407-9-82|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.